ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
288.38
-0.68 (-0.24%)
Aug 21, 2025, 4:00 PM - Market closed
ResMed Stock Forecast
Stock Price Forecast
The 11 analysts that cover ResMed stock have a consensus rating of "Buy" and an average price target of $276.82, which forecasts a -4.01% decrease in the stock price over the next year. The lowest target is $180 and the highest is $325.
Price Target: $276.82 (-4.01%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ResMed stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 4 | 4 | 4 | 6 | 6 |
| Hold | 5 | 5 | 5 | 5 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 13 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $270 → $290 | Buy | Maintains | $270 → $290 | +0.56% | Aug 1, 2025 |
| Stifel | Stifel | Hold Maintains $240 → $270 | Hold | Maintains | $240 → $270 | -6.37% | Aug 1, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $294 → $300 | Buy | Maintains | $294 → $300 | +4.03% | Aug 1, 2025 |
| UBS | UBS | Strong Buy Maintains $285 → $325 | Strong Buy | Maintains | $285 → $325 | +12.70% | Aug 1, 2025 |
| Keybanc | Keybanc | Buy Maintains $274 → $298 | Buy | Maintains | $274 → $298 | +3.34% | Aug 1, 2025 |
Financial Forecast
Revenue This Year
5.60B
from 5.15B
Increased by 8.76%
Revenue Next Year
6.00B
from 5.60B
Increased by 7.16%
EPS This Year
10.58
from 9.51
Increased by 11.25%
EPS Next Year
11.58
from 10.58
Increased by 9.48%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 6.0B | 6.5B | 6.8B | |
| Avg | 5.6B | 6.0B | 6.4B | |
| Low | 5.3B | 5.6B | 6.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 16.6% | 15.5% | 13.7% | |
| Avg | 8.8% | 7.2% | 7.4% | |
| Low | 3.3% | 0.6% | 2.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 11.72 | 13.00 | 13.20 | |
| Avg | 10.58 | 11.58 | 12.50 | |
| Low | 9.80 | 10.38 | 11.94 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 23.2% | 22.9% | 14.0% | |
| Avg | 11.2% | 9.5% | 7.9% | |
| Low | 3.0% | -1.9% | 3.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.